Moreover, the situation mimics the status during a primary infection, when the host lacks immunity to VZV; thus, the shortage of existing neutralizing antibodies may have induced new B‐cell clones to produce VZV‐specific IgM antibodies in these patients. The gene discussed is CD40LG; the disease is infection.